People · Operator
Named in public records as an officer, director or promoter · active 2017–2026 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Entera Bio Ltd. | — | Biotechnology | Series A | $22.2M | $44.8M | 2017 |
| Dosentrx Ltd. | — | Pharmaceuticals | Seed | $1.8M | $3.6M | 2026 |
Gerald Lieberman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gerald Lieberman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ron Mayron | 1 | 6 |
| Faith Charles | 1 | 4 |
| Daniel Beck | 1 | 4 |
| Adam Gridley | 1 | 4 |
| Sean Ellis | 1 | 3 |
| Gerald Ostrov | 1 | 3 |
| Mark Summers | 1 | 3 |
| Miranda Toledano | 1 | 3 |
| Yonatan Malca | 1 | 2 |
| Zeev Bronfeld | 1 | 2 |
| Frank Sheehy | 1 | 2 |
| Gerald M. Ostrov | 1 | 2 |
| Roger M. Garceau | 1 | 1 |
| Chaim M. Davis | 1 | 1 |
| Luke M. Beshar | 1 | 1 |
| Zeev M. Bronfeld | 1 | 1 |
| Yonatan M. Malca | 1 | 1 |
| Alan Paz | 1 | 1 |
| Jon Roberts | 1 | 1 |
| Liron Levi-Gabay | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.